NEK7 and diabetic retinopathy: In order to verify whether MCC950 can block the NEK7/NLRP3 pathway in diabetic retinopathy by binding specifically with NLRP3 and thus achieve the therapeutic effect, we used immunofluorescence localization (Fig. 4A) to analyze the NEK7 expression level in the retina.